CERo Therapeutics Statistics Share Statistics CERo Therapeutics has 1.19M
shares outstanding. The number of shares has increased by 0.2%
in one year.
Shares Outstanding 1.19M Shares Change (YoY) 0.2% Shares Change (QoQ) 0.19% Owned by Institutions (%) n/a Shares Floating 1.15M Failed to Deliver (FTD) Shares 1,358 FTD / Avg. Volume 0.12%
Short Selling Information The latest short interest is 16.27K, so 2.59% of the outstanding
shares have been sold short.
Short Interest 16.27K Short % of Shares Out 2.59% Short % of Float 2.71% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -18.75 and the forward
PE ratio is -0.14.
CERo Therapeutics's PEG ratio is
0.19.
PE Ratio -18.75 Forward PE -0.14 PS Ratio 0 Forward PS n/a PB Ratio -76.51 P/FCF Ratio -25.04 PEG Ratio 0.19
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for CERo Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.5,
with a Debt / Equity ratio of -0.83.
Current Ratio 0.5 Quick Ratio 0.5 Debt / Equity -0.83 Debt / EBITDA -0.24 Debt / FCF -0.27 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-966.5K Employee Count 8 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -97.29% in the
last 52 weeks. The beta is 0.49, so CERo Therapeutics's
price volatility has been higher than the market average.
Beta 0.49 52-Week Price Change -97.29% 50-Day Moving Average 8.82 200-Day Moving Average 78.22 Relative Strength Index (RSI) 46.5 Average Volume (20 Days) 1,126,517
Income Statement
Revenue n/a Gross Profit n/a Operating Income -15.3M Net Income -7.73M EBITDA -6.57M EBIT -7.73M Earnings Per Share (EPS) -6.87
Full Income Statement Balance Sheet The company has 3.33M in cash and 1.58M in
debt, giving a net cash position of 1.75M.
Cash & Cash Equivalents 3.33M Total Debt 1.58M Net Cash 1.75M Retained Earnings -70.92M Total Assets 7.99M Working Capital -2.09M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -5.79M
and capital expenditures -1, giving a free cash flow of -5.79M.
Operating Cash Flow -5.79M Capital Expenditures -1 Free Cash Flow -5.79M FCF Per Share -4.79
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields CERO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CERO is $45,
which is 474% higher than the current price. The consensus rating is "Buy".
Price Target $45 Price Target Difference 474% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 13, 2025. It was a
backward
split with a ratio of 1:20.
Last Split Date Jun 13, 2025 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -18.75 Piotroski F-Score 2
